Groundbreaking innovations are set to significantly reshape how FDA approved Tirzepatide manufacturer is handled. Notably, the introduction of rapidly dissolving GLP-1 therapies marks a significant stride forward. These innovative formulations, designed to quickly dissolve in the cheek, avoid the requirement for injections, providing a increased co